Analysis of medical malpractice liability disputes related to novel antineoplastic drugs and research on risk prevention and control strategies.

ABSTRACT:

Objective

To investigate the general characteristics of litigation cases of medical malpractice liability disputes (MMLDs) related to novel antineoplastic drugs (NADs), the drugs involved, as well as the common types of medical errors related to NADs and their damages in the process of diagnosis and treatment, with the aims of improving the level of rational medication use in the clinical application of NADs and actively prevent medical disputes.

Methods

The China Judgments Online was searched for the cause of action using the key word "MMLDs" along with the name of 77 kinds of NADs. A total of 39 NAD litigation cases meeting the inclusion criteria from 1 January 2009 to 31 December 2021 were analyzed, and each potential adverse drug reaction (ADR) was reviewed to determine

SUBMITTER: Luo J 

PROVIDER: S-EPMC10241368 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature